Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis)Research in context

Summary: Background: Erdheim-Chester disease (ECD) is a rare histiocytosis that may overlap with Langerhans Cell Histiocytosis (LCH). This “mixed” entity is poorly characterized. We here investigated the clinical phenotype, outcome, and prognostic factors of a large cohort of patients with mixed EC...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Francesco Pegoraro, Matthias Papo, Fleur Cohen-Aubart, Francesco Peyronel, Gianmarco Lugli, Irene Trambusti, Gildas Baulier, Mathilde de Menthon, Tanguy Le Scornet, Eric Oziol, Nicole Ferreira-Maldent, Olivier Hermine, Benoit Faucher, Dirk Koschel, Nicole Straetmans, Noémie Abisror, Benjamin Terrier, François Lifermann, Jerome Razanamahery, Yves Allenbach, Jeremy Keraen, Sophie Bulifon, Baptiste Hervier, Annamaria Buccoliero, Frederic Charlotte, Quentin Monzani, Samia Boussouar, Natalia Shor, Annalisa Tondo, Stephane Barete, Ahmed Idbaih, Abdellatif Tazi, Elena Sieni, Zahir Amoura, Jean-François Emile, Augusto Vaglio, Julien Haroche
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Elsevier 2024-07-01
Rangatū:	EClinicalMedicine
Ngā marau:	Erdheim-Chester disease Langerhans BRAF Histiocytosis Mixed histiocytosis Pediatric histiocytosis
Urunga tuihono:	http://www.sciencedirect.com/science/article/pii/S2589537024002372
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!